Holen Sie sich die Stockscreener-App
1.77
3.51%
0.06
Handel nachbörslich:
1.80
0.03
+1.69%
Schlusskurs vom Vortag:
$1.71
Offen:
$1.71
24-Stunden-Volumen:
1.05M
Relative Volume:
1.09
Marktkapitalisierung:
$127.68M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-292.19M
KGV:
-0.3899
EPS:
-4.54
Netto-Cashflow:
$-208.41M
1W Leistung:
+0.57%
1M Leistung:
+27.34%
6M Leistung:
-5.35%
1J Leistung:
-45.54%
1-Tages-Spanne:
$1.60
$1.79
1-Wochen-Bereich:
$1.60
$1.82
52-Wochen-Spanne:
$1.01
$5.44
Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile
Firmenname
Zentalis Pharmaceuticals Inc
Sektor
Branche
Telefon
(858) 263-4333
Adresse
10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY
Vergleichen Sie ZNTL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZNTL
Zentalis Pharmaceuticals Inc
|
1.77 | 124.07M | 0 | -292.19M | -208.41M | -4.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-12 | Hochstufung | Wedbush | Underperform → Neutral |
| 2024-06-20 | Herabstufung | UBS | Buy → Neutral |
| 2024-06-18 | Herabstufung | Jefferies | Buy → Hold |
| 2024-06-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-18 | Herabstufung | Wedbush | Neutral → Underperform |
| 2024-06-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-11-08 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2022-07-12 | Eingeleitet | Cowen | Outperform |
| 2022-04-06 | Eingeleitet | Wells Fargo | Overweight |
| 2021-10-07 | Fortgesetzt | Jefferies | Buy |
| 2021-09-30 | Eingeleitet | Stifel | Buy |
| 2021-09-29 | Eingeleitet | Oppenheimer | Outperform |
| 2021-05-21 | Eingeleitet | UBS | Buy |
| 2021-01-20 | Eingeleitet | Wedbush | Outperform |
| 2020-09-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-08-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-28 | Eingeleitet | Guggenheim | Buy |
| 2020-04-28 | Eingeleitet | Jefferies | Buy |
| 2020-04-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-04-28 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Zentalis Pharmaceuticals Inc Aktie (ZNTL) Neueste Nachrichten
Zentalis Pharmaceuticals shares fall 1.45% intraday after announcing inducement grants to new employees. - AInvest
Why Zentalis Pharmaceuticals Inc. is moving todayTrade Volume Report & Short-Term High Return Ideas - Newser
Using R and stats models for Zentalis Pharmaceuticals Inc. forecastingJuly 2025 Retail & Growth Focused Stock Reports - Newser
Using data tools to time your Zentalis Pharmaceuticals Inc. exitSwing Trade & Community Trade Idea Sharing - Newser
Zentalis Pharmaceuticals Inc. stock momentum explainedJuly 2025 Snapshot & Fast Moving Market Watchlists - Newser
Will Zentalis Pharmaceuticals Inc. stock recover after earningsJuly 2025 Breakouts & Risk Managed Investment Strategies - khodrobank.com
Using Ichimoku Cloud for Zentalis Pharmaceuticals Inc. technicalsQuarterly Performance Summary & Reliable Price Breakout Signals - Newser
Published on: 2025-09-03 05:20:27 - Newser
Will Zentalis Pharmaceuticals Inc. outperform small cap indexesWeekly Profit Analysis & Safe Capital Growth Tips - khodrobank.com
How to use Fibonacci retracement on Zentalis Pharmaceuticals Inc.Trade Risk Summary & Long-Term Capital Growth Ideas - Newser
Using portfolio simulators with Zentalis Pharmaceuticals Inc. includedJuly 2025 Reactions & Safe Capital Growth Plans - Newser
Is Zentalis Pharmaceuticals Inc. impacted by rising ratesCEO Change & Safe Investment Capital Preservation Plans - khodrobank.com
Heatmap analysis for Zentalis Pharmaceuticals Inc. and competitorsBuy Signal & Real-Time Volume Surge Alerts - Newser
Advanced analytics toolkit walkthrough for Zentalis Pharmaceuticals Inc.July 2025 PostEarnings & Step-by-Step Swing Trade Plans - Newser
Understanding Zentalis Pharmaceuticals Inc.’s price movementJuly 2025 Closing Moves & Low Risk Investment Opportunities - Newser
Can Zentalis Pharmaceuticals Inc. deliver consistent EPS growth2025 Trading Volume Trends & Long-Term Capital Growth Strategies - khodrobank.com
Tools to monitor Zentalis Pharmaceuticals Inc. recovery probabilityBuy Signal & Accurate Buy Signal Notifications - Newser
Zentalis Pharmaceuticals announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Zentalis Pharmaceuticals Grants Stock Options to New Employees as Part of Inducement Plan - Quiver Quantitative
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
381,000 Shares: Zentalis Pharmaceuticals Awards Major Stock Options Package to New Executive Hires - Stock Titan
What are the risks of holding Zentalis Pharmaceuticals Inc.Earnings Beat & Long-Term Growth Plans - khodrobank.com
Can Zentalis Pharmaceuticals Inc. weather a recessionJuly 2025 Levels & Community Driven Trade Alerts - khodrobank.com
Is Zentalis Pharmaceuticals Inc. stock showing strong momentumJuly 2025 Opening Moves & Stock Portfolio Risk Management - khodrobank.com
Can volume confirm reversal in Zentalis Pharmaceuticals Inc.Market Risk Summary & Proven Capital Preservation Methods - Newser
Is Zentalis Pharmaceuticals Inc. forming a bullish divergence2025 Technical Patterns & Weekly Stock Performance Updates - khodrobank.com
Long term hold vs stop loss in Zentalis Pharmaceuticals Inc.2025 Institutional Moves & AI Powered Market Trend Analysis - Newser
Zentalis Pharmaceuticals Inc. stock outlook for YEARWeekly Trade Recap & Consistent Income Trade Recommendations - Newser
What to do if you’re stuck in Zentalis Pharmaceuticals Inc.Trade Risk Report & Long-Term Safe Investment Plans - Newser
Should you hold or exit Zentalis Pharmaceuticals Inc. nowMarket Sentiment Review & Stock Portfolio Risk Management - Newser
Tick level data insight on Zentalis Pharmaceuticals Inc. volatilityWeekly Investment Report & Entry Point Confirmation Signals - Newser
Published on: 2025-08-31 06:27:08 - Newser
Technical signs of recovery in Zentalis Pharmaceuticals Inc.Weekly Stock Analysis & Free Weekly Watchlist of Top Performers - Newser
Sector Rotation Brings Zentalis Pharmaceuticals Inc. Into Focus getLinesFromResByArray error: size == 0 - 더경남뉴스
Visualizing Zentalis Pharmaceuticals Inc. stock with heatmapsJuly 2025 Big Picture & Technical Pattern Recognition Alerts - Newser
Finanzdaten der Zentalis Pharmaceuticals Inc-Aktie (ZNTL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Zentalis Pharmaceuticals Inc-Aktie (ZNTL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bruns Ingmar | Chief Medical Officer |
Feb 06 '25 |
Buy |
2.28 |
20,000 |
45,656 |
36,629 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):